PERCEPTIVE ADVISORS LLC
NEW YORK, NY · CIK 1224962 · 13F filing filed 2022-08-15
SEC-registered investment adviser since 2010 · limited liability company
- Assets managed$11.8bn
- Staff49 · 28 in investment roles
- Main clients (by assets)Private funds 99%
- Private funds17 (6 hedge) · $11.7bn gross assets
- Form ADV · 2026-07-13SEC adviser record
- Legal entityPERCEPTIVE ADVISORS LLC (US)
- Kindhedge funds, private equity, venture, futures
- Others nearbyNew York, NY, Greenwich, CT, Miami Beach, FL, Sheridan, WY, Water Mill, NY
As an employer
- Offices in1 country
- Private fundshedge 6, venture capital 2, private equity 5, other private 4
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 25 |
| Greenwich, CTUnited States | 1 |
| Miami Beach, FLUnited States | 1 |
| Sheridan, WYUnited States | 1 |
| Water Mill, NYUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 0 call positions (— notional), 2 put positions ($10.2m notional) – listed below, not included above.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| TRAVERE THERAPEUTICS INC TVTX 2.25 03.01.29 · principal | $455.9m14.33% | Unchanged |
| AMICUS THERAPEUTICS INC FOLD | $288.9m9.08% | Reduced -660.3k |
| MIRATI THERAPEUTICS INC MRTX | $192.5m6.05% | Added +486.2k |
| CEREVEL THERAPEUTICS HLDNG I CERE | $134.5m4.23% | Unchanged |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $130.6m4.10% | Reduced -375.0k |
| LIANBIO LIANY | $122.2m3.84% | Added +240.3k |
| CRINETICS PHARMACEUTICALS IN CRNX | $99.2m3.12% | Added +157.5k |
| GLOBAL BLOOD THERAPEUTICS IN GBT | $96.3m3.03% | Reduced -877.4k |
| SPRINGWORKS THERAPEUTICS INC SWTX | $95.2m2.99% | Reduced -660.5k |
| AMYLYX PHARMACEUTICALS INC AMLX | $68.2m2.14% | Added +2.1m |
| XENON PHARMACEUTICALS INC XENE | $64.6m2.03% | Reduced -288.9k |
| MEIRAGTX HLDGS PLC MGTX | $52.7m1.66% | Added +15.0k |
| LYRA THERAPEUTICS INC LYRA | $51.7m1.62% | Added +5.9m |
| BELLUS HEALTH INC NEW BLU | $51.1m1.61% | Reduced -2.6m |
| PROMETHEUS BIOSCIENCES INC COM | $47.5m1.49% | Reduced -758.3k |
| ALBIREO PHARMA INC BIOD | $46.9m1.47% | Unchanged |
| CINCOR PHARMA INC COM | $43.7m1.37% | Unchanged |
| VBI VACCINES INC CDA COM NEW | $42.3m1.33% | Unchanged |
| SEAGEN INC SGEN | $39.6m1.25% | New |
| VERU INC COM | $39.5m1.24% | Reduced -862.0k |
| ALDEYRA THERAPEUTICS INC ALDX | $39.5m1.24% | Unchanged |
| NEUROCRINE BIOSCIENCES INC NBIX | $38.8m1.22% | Added +2.2k |
| RAPT THERAPEUTICS INC COM | $34.9m1.10% | Reduced -886.2k |
| RELAY THERAPEUTICS INC RLAY | $32.5m1.02% | Unchanged |
| ELI LILLY & CO LLY | $32.4m1.02% | New |
| COHERUS BIOSCIENCES INC CHRS 1.5 04.15.26 · principal | $29.5m0.93% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $27.9m0.88% | Reduced -99.8k |
| COHERUS BIOSCIENCES INC CHRS | $26.4m0.83% | Reduced -1.1m |
| MADRIGAL PHARMACEUTICALS INC MDGL | $26.3m0.83% | Added +89.2k |
| ALNYLAM PHARMACEUTICALS INC ALNY | $25.2m0.79% | Reduced -7.1k |
| NAUTILUS BIOTECHNOLOGY INC NAUT | $24.5m0.77% | Unchanged |
| PROCEPT BIOROBOTICS CORP PRCT | $24.5m0.77% | Reduced -738.6k |
| ADMA BIOLOGICS INC ADMA | $22.8m0.72% | Reduced -412.3k |
| NUVALENT INC COM | $22.4m0.71% | Reduced -96.6k |
| ESTABLISHMENT LABS HLDGS INC ESTA | $22.1m0.69% | Reduced -44.6k |
| ZYMEWORKS INC ZYME | $21.9m0.69% | Reduced -1.2m |
| IMMATICS N.V IMTX | $21.8m0.68% | Unchanged |
| INHIBRX INC INBX | $21.7m0.68% | Added +133.4k |
| ARCELLX INC ACLX | $20.6m0.65% | New |
| IVERIC BIO INC OPHT | $20.1m0.63% | Reduced -3.1m |
| HARMONY BIOSCIENCES HLDGS IN HRMY | $20.1m0.63% | New |
| TARSUS PHARMACEUTICALS INC TARS | $18.9m0.59% | Unchanged |
| ARTIVION INC AORT | $17.6m0.55% | Added +314.0k |
| DICE THERAPEUTICS INC COM | $16.3m0.51% | Reduced -463.5k |
| ROCKET PHARMACEUTICALS INC RCKT | $16.1m0.50% | Reduced -511.2k |
| BRIDGEBIO PHARMA INC BBIO | $15.4m0.48% | Reduced -2.1m |
| BIOMARIN PHARMACEUTICAL INC BMRN | $14.9m0.47% | New |
| OUTSET MED INC OM | $14.8m0.47% | Reduced -884.7k |
| ATHIRA PHARMA INC COM | $14.6m0.46% | Added +1.4m |
| APELLIS PHARMACEUTICALS INC APLS | $14.5m0.46% | Reduced -1.2m |
| TRAVERE THERAPEUTICS INC TVTX | $13.8m0.43% | Reduced -1.3m |
| RAIN ONCOLOGY INC COM | $13.8m0.43% | Unchanged |
| SINGULAR GENOMICS SYSTEMS IN COM | $13.5m0.42% | Reduced -118.9k |
| TREACE MED CONCEPTS INC TMCI | $13.5m0.42% | Reduced -30.0k |
| VERONA PHARMA PLC VRNA | $12.2m0.38% | Reduced -129.2k |
| VIRIDIAN THERAPEUTICS INC VRDN | $11.2m0.35% | Reduced -451.2k |
| CHEMOCENTRYX INC CCXI | $10.9m0.34% | Reduced -1.2m |
| CAREMAX INC COM CL A | $10.9m0.34% | Reduced -186.7k |
| LANDOS BIOPHARMA INC COM | $10.8m0.34% | Unchanged |
| DAY ONE BIOPHARMACEUTICALS I COM | $10.0m0.31% | Unchanged |
| VERRICA PHARMACEUTICALS INC COM | $9.7m0.30% | Added +1.4m |
| LEAP THERAPEUTICS INC LPTX | $9.1m0.29% | Unchanged |
| CONCERT PHARMACEUTICALS INC CNCE | $9.1m0.28% | Unchanged |
| ISOPLEXIS CORP COM | $8.8m0.28% | Unchanged |
| KRONOS BIO INC KRON | $8.8m0.28% | Unchanged |
| HILLEVAX INC COM | $8.4m0.26% | New |
| SOLID BIOSCIENCES INC COM | $8.3m0.26% | Unchanged |
| PRIVIA HEALTH GROUP INC PRVA | $8.0m0.25% | Added +60.0k |
| REVANCE THERAPEUTICS INC RVNC | $7.9m0.25% | Added +435.0k |
| MORPHIC HLDG INC MORF | $7.9m0.25% | Reduced -404.1k |
| POINT BIOPHARMA GLOBAL INC COM | $7.3m0.23% | Reduced -120.0k |
| SOMALOGIC INC SLGC | $6.8m0.21% | Unchanged |
| HEALTH CATALYST INC HCAT | $6.7m0.21% | Reduced -28.5k |
| SEMA4 HOLDINGS CORP SMFR | $6.3m0.20% | Added +2.5m |
| ICOSAVAX INC COM | $6.0m0.19% | Reduced -336.3k |
| C4 THERAPEUTICS INC CCCC | $5.8m0.18% | Reduced -1.3m |
| NUVATION BIO INC NUVB | $5.7m0.18% | Unchanged |
| ATHENEX INC ATNX | $5.5m0.17% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $4.8m0.15% | Reduced -42.0k |
| NANOBIOTIX NBTX | $4.0m0.13% | Unchanged |
| QUOTIENT LTD SHS | $3.9m0.12% | Unchanged |
| ASTRIA THERAPEUTICS INC CATB | $3.8m0.12% | Unchanged |
| PYXIS ONCOLOGY INC PYXS | $3.6m0.11% | Unchanged |
| MACROGENICS INC MGNX | $3.6m0.11% | Reduced -332.6k |
| TYRA BIOSCIENCES INC TYRA | $3.5m0.11% | Unchanged |
| CLOVER HEALTH INVESTMENTS CO CLOV | $3.2m0.10% | Unchanged |
| Y-MABS THERAPEUTICS INC YMAB | $3.2m0.10% | New |
| SCIENCE 37 HOLDINGS INC COM | $3.0m0.09% | Unchanged |
| ABSCI CORPORATION ABSI | $3.0m0.09% | Reduced -296.6k |
| ENVVENO MEDICAL CORPORATION COM | $3.0m0.09% | Unchanged |
| FUSION PHARMACEUTICALS INC COM | $2.6m0.08% | Reduced -174.6k |
| HYPERFINE INC HYPR | $2.5m0.08% | Reduced -365.6k |
| ACUMEN PHARMACEUTICALS INC ABOS | $2.4m0.08% | Reduced -88.4k |
| RELMADA THERAPEUTICS INC RLMD | $2.3m0.07% | Reduced -30.0k |
| DARIOHEALTH CORP DRIO | $2.0m0.06% | Unchanged |
| FULCRUM THERAPEUTICS INC FULC | $1.4m0.05% | Unchanged |
| PEAR THERAPEUTICS INC CLASS A COM | $1.4m0.04% | Reduced -25.7k |
| FERRARI N V RACE | $1.1m0.04% | Unchanged |
| SONENDO INC COM | $1.1m0.04% | Reduced -20.0k |
| ZYMERGEN INC ZY | $1.1m0.03% | Unchanged |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| AGILE THERAPEUTICS INC AGRX | $178.4m21.3m shares |
| HORIZON THERAPEUTICS PUB L HZNP | $142.9m1.4m shares |
| COLLEGIUM PHARMACEUTICAL INC COLL 2.625 02.15.26 | $89.5m9.5m shares |
| NEVRO CORP NVRO | $34.5m477.0k shares |
| PENUMBRA INC PEN | $31.9m143.6k shares |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $23.1m501.5k shares |
| LEGEND BIOTECH CORP LEGN | $22.4m616.1k shares |
| AXONICS INC AXNX | $21.4m341.2k shares |
| PULMONX CORP LUNG | $13.3m537.8k shares |
| ARCUS BIOSCIENCES INC RCUS | $12.8m405.0k shares |
| NANOSTRING TECHNOLOGIES INC NSTG 2.625 03.01.25 | $11.0m1.0m shares |
| CUE HEALTH INC HLTHQ | $10.2m1.6m shares |
| BCLS ACQUISITION CORP | $9.9m1.0m shares |
| SUMMIT HEALTHCRE ACQUISTN CO | $9.8m1.0m shares |
| RESEARCH ALLIANCE CORP II | $9.8m1.0m shares |
| EVOLENT HEALTH INC EVH | $8.1m250.0k shares |
| ACADIA PHARMACEUTICALS INC ACAD | $6.9m284.9k shares |
| ACCOLADE INC ACCD | $5.8m330.7k shares |
| MERUS N V MRUS | $5.5m209.0k shares |
| DA32 LIFE SCNCE TEC ACQSTN C | $4.9m500.0k shares |
| SIGHT SCIENCES INC SGHT | $4.5m390.0k shares |
| HEALTH SCIENCES ACQ CORP 2 OBIO | $4.5m450.0k shares |
| INVITAE CORP NVTA | $4.4m554.6k shares |
| IMMUNEERING CORP IMRX | $4.4m681.1k shares |
| INARI MED INC NARI | $2.7m30.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Put | $7.4m100.0k shares | New |
| CASSAVA SCIENCES INC FLNA · Put | $2.8m100.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 38.
| Company | Stake |
|---|---|
| ADAGIO MED HLDGS INC ADGM · 13G · filed 2026-05-15 | 55.4%≈ $8.8m |
| LEONABIO INC LONA · 13D · filed 2026-10-26 | 20.0%≈ $17.4m |
| LYRA THERAPEUTICS INC LYRA · 13D · filed 2025-08-14 | 15.6% |
| MEIRAGTX HLDGS PLC MGTX · 13D · filed 2026-04-24 | 12.6%≈ $158.6m |
| SOLID BIOSCIENCES INC SLDB · 13D · filed 2026-08-14 | 11.2%≈ $120.3m |
| PERCEPTIVE CAP SOLUTIONS COR FRNM · 13G · filed 2026-07-23 | 10.1% |
| INHIBRX BIOSCIENCES INC INBX · 13G · filed 2026-08-14 | 10.0%≈ $141.1m |
| ALTO NEUROSCIENCE INC ANRO · 13G · filed 2026-08-14 | 10.0%≈ $110.2m |
| OPUS GENETICS INC IRD · 13G · filed 2026-08-14 | 10.0%≈ $37.6m |
| ENGENE HOLDINGS INC 13G · filed 2026-08-14 | 10.0% |
| KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-10 | 10.0%≈ $1.2m |
| ENVVENO MEDICAL CORPORATION 13G · filed 2026-02-17 | 10.0% |
| ORCHESTRA BIOMED HLDGS INC OBIO · 13G · filed 2025-11-14 | 10.0%≈ $24.5m |
| TRINITY BIOTECH PLC 13D · filed 2026-05-04 | 9.9% |
| OUTSET MED INC OM · 13G · filed 2025-02-28 | 9.5% |
| NAUTILUS BIOTECHNOLOGY INC NAUT · 13D · filed 2026-08-14 | 9.1%≈ $21.8m |
| KARDIGAN INC KARD · 13D · filed 2026-10-01 | 8.8%≈ $196.9m |
| QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-10-14 | 8.4%≈ $1.7m |
| RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-05-28 | 8.2%≈ $8.0m |
| X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 | 8.1%≈ $37.8m |
| SUTRO BIOPHARMA INC STRO · 13G · filed 2026-08-14 | 7.9%≈ $43.3m |
| PALISADE BIO INC PALI · 13G · filed 2026-05-15 | 7.9%≈ $29.5m |
| IMMATICS N.V IMTX · 13D · filed 2026-08-27 | 7.6%≈ $113.5m |
| AMYLYX PHARMACEUTICALS INC AMLX · 13G · filed 2026-05-15 | 7.5%≈ $148.8m |
| SAB BIOTHERAPEUTICS INC SABS · 13G · filed 2026-08-14 | 7.3%≈ $25.8m |
Trades reported as a company insider in Q2 2022
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2022-06-30 | LEONABIO INC Director · See Footnote | Bought | $3.3m1.1m shares |
| 2022-06-29 | LEONABIO INC Director · See Footnote | Bought | $807.3k270.0k shares |